NL-005
- Generic Name
- NL-005
A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2020-09-29
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT04555824
- Locations
- 🇨🇳
Beijing Shijitan Hospital, Beijing, China
A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2020-09-29
- Lead Sponsor
- Beijing Northland Biotech. Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT04555850
- Locations
- 🇨🇳
Beijing Shijitan Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath